BR112022023058A2 - Derivado de 1,4,5,6-tetrahidropirimidin-2-amina - Google Patents
Derivado de 1,4,5,6-tetrahidropirimidin-2-aminaInfo
- Publication number
- BR112022023058A2 BR112022023058A2 BR112022023058A BR112022023058A BR112022023058A2 BR 112022023058 A2 BR112022023058 A2 BR 112022023058A2 BR 112022023058 A BR112022023058 A BR 112022023058A BR 112022023058 A BR112022023058 A BR 112022023058A BR 112022023058 A2 BR112022023058 A2 BR 112022023058A2
- Authority
- BR
- Brazil
- Prior art keywords
- group
- hydrogen atom
- tetrahydropyrimidin
- amine derivative
- atom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
DERIVADO DE 1,4,5,6-TETRAHIDROPIRIMIDIN-2-AMINA. É fornecido um composto representado pelas seguintes fórmulas gerais (I) ou (II) ou um sal farmaceuticamente aceitável do mesmo, em que A é um grupo C6-C10 arila ou um grupo heteroarila, em que pelo menos um átomo de hidrogênio do grupo arila ou do grupo heteroarila é opcionalmente substituído com um substituinte selecionado a partir de um grupo predeterminado, R é um átomo de hidrogênio ou um grupo C1-C6 alquila, R1 é um átomo de hidrogênio ou um átomo de halogênio e Y é um átomo de hidrogênio, um átomo de flúor ou um grupo hidroxi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020085420 | 2020-05-14 | ||
PCT/JP2021/018252 WO2021230325A1 (ja) | 2020-05-14 | 2021-05-13 | 1,4,5,6-テトラヒドロピリミジン-2-アミン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022023058A2 true BR112022023058A2 (pt) | 2022-12-20 |
Family
ID=78524455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022023058A BR112022023058A2 (pt) | 2020-05-14 | 2021-05-13 | Derivado de 1,4,5,6-tetrahidropirimidin-2-amina |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230192661A1 (pt) |
EP (1) | EP4151632A4 (pt) |
JP (1) | JPWO2021230325A1 (pt) |
KR (1) | KR20230011967A (pt) |
CN (1) | CN115551846B (pt) |
AU (1) | AU2021270095A1 (pt) |
BR (1) | BR112022023058A2 (pt) |
CA (1) | CA3182964A1 (pt) |
MX (1) | MX2022014200A (pt) |
WO (1) | WO2021230325A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023085396A1 (ja) * | 2021-11-12 | 2023-05-19 | Ube株式会社 | アルポート症候群を治療または予防するための医薬組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6028223A (en) | 1995-08-30 | 2000-02-22 | G. D. Searle & Co. | Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid compounds and derivatives thereof |
US6372719B1 (en) | 1998-03-04 | 2002-04-16 | Jay Cunningham | ανβ3 integrin antagonists in combination with chemotherapeutic agents |
ZA994406B (en) | 1998-03-04 | 2000-02-11 | Searle & Co | Meta-azacyclic amino benzoic acid and derivatives thereof. |
BR9910119A (pt) * | 1998-04-10 | 2001-10-09 | Searle & Co | Derivados heterocìclicos de glicil beta-alanina como antagonistas de vitronectina |
BR0317487A (pt) | 2002-12-20 | 2005-11-29 | Pharmacia Corp | O r-isÈmero de compostos de aminoácido beta como derivados de antagonistas de receptores de integrina |
US8716226B2 (en) | 2012-07-18 | 2014-05-06 | Saint Louis University | 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists |
US9085606B2 (en) * | 2012-07-18 | 2015-07-21 | Saint Louis University | Beta amino acid derivatives as integrin antagonists |
ES2806276T3 (es) * | 2015-12-30 | 2021-02-17 | Univ Saint Louis | Derivados de ácido aminobenzoico meta-azaciclicos como antagonistas pan-integrina |
-
2021
- 2021-05-13 WO PCT/JP2021/018252 patent/WO2021230325A1/ja unknown
- 2021-05-13 CN CN202180034572.XA patent/CN115551846B/zh active Active
- 2021-05-13 AU AU2021270095A patent/AU2021270095A1/en active Pending
- 2021-05-13 EP EP21803967.5A patent/EP4151632A4/en active Pending
- 2021-05-13 MX MX2022014200A patent/MX2022014200A/es unknown
- 2021-05-13 US US17/924,942 patent/US20230192661A1/en active Pending
- 2021-05-13 CA CA3182964A patent/CA3182964A1/en active Pending
- 2021-05-13 KR KR1020227042726A patent/KR20230011967A/ko active Search and Examination
- 2021-05-13 BR BR112022023058A patent/BR112022023058A2/pt unknown
- 2021-05-13 JP JP2022522202A patent/JPWO2021230325A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPWO2021230325A1 (pt) | 2021-11-18 |
AU2021270095A1 (en) | 2022-12-22 |
CN115551846B (zh) | 2024-03-08 |
EP4151632A1 (en) | 2023-03-22 |
KR20230011967A (ko) | 2023-01-25 |
US20230192661A1 (en) | 2023-06-22 |
MX2022014200A (es) | 2022-12-07 |
WO2021230325A1 (ja) | 2021-11-18 |
CN115551846A (zh) | 2022-12-30 |
CA3182964A1 (en) | 2021-11-18 |
EP4151632A4 (en) | 2024-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108481T1 (el) | Ενωσεις 2,3-διϋδρο-6-νιτροϊμιδαζο[2,1-β]οξαζολιου για τη θεραπεια φυματιωσης | |
CL2020003386A1 (es) | Agente profiláctico o terapéutico para atrofia muscular espinal | |
EA201101089A1 (ru) | Производные оксадиазола в качестве агонистов рецептора s1p1 | |
DE602004022404D1 (de) | 4-anilino-chinazolin-derivate als proliferationshemmende mittel | |
ES2188016T3 (es) | Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas. | |
BR122019003178B1 (pt) | método de controle de pestes | |
UA91470C2 (ru) | Нематоцидная композиция, способ борьбы с нематодами и применение производной n-2-(пиридил) этилкарбоксамида в качестве нематоцида | |
BR112014029501A2 (pt) | composto heterocíclico fundido | |
CY1117923T1 (el) | Αζωτουχος ετεροκυκλικη ενωση και γεωργικο ή κηπουρικο μυκητοκτονο | |
BRPI0817973A2 (pt) | derivados de nicotinamida, o respectivo preparo e a respectiva aplicação em terapêutica | |
DK0636622T3 (da) | Isoxazolderivater samt deres anvendelse som herbicider | |
NO20053449L (no) | 3-substituerte 4-pyrimidonderivater | |
TNSN07178A1 (fr) | N-sulfonylaminobenzyl-2-phenoxy-acetamides substitues | |
CR10034A (es) | Derivados de oxadiazol | |
NO20075650L (no) | Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater | |
BR112022023058A2 (pt) | Derivado de 1,4,5,6-tetrahidropirimidin-2-amina | |
MX2021008252A (es) | Compuesto de pirimidina o sal del mismo. | |
KR890006590A (ko) | 4-아미노피리딘 유도체 | |
BR112018069551A2 (pt) | composto heterocíclico. | |
ATE169921T1 (de) | Optisch aktive beta-aminoalkoxyborankomplexe | |
DE69617909T2 (de) | 2-substituierte vitamin-d3-derivate | |
CY1105158T1 (el) | Εκδοχα πυριδοϊνδολονης που φερει υποκαταστατη στο -3 μια ετepοκυκλικη ομαδα, η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη | |
MX2022002362A (es) | Derivado de 2-aminoquinazolinona. | |
BR112018008885A2 (pt) | composto heterocíclico condensado | |
DK1163258T3 (da) | Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis |